EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Comparison of Respiratory Syncytial Virus (RSV)–Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination

Alisa Kachikis iD, Collrane Frivold iD, Mindy Pike iD, Jonathan C Reed iD, Jennifer E Stolarczuk iD, Kittredge McVey iD, Erica Clark iD, Clarice Mauer, Sandra McAteer, Ioana Maria Saidac, Alex Harteloo, Marco Carone iD und 5 weitere

The Journal of Infectious Diseases · 03.08.2026 · 234 (1) · e54-e59

DOI: 10.1093/infdis/jiag111 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 26.03.2026. Verfasst von Alisa Kachikis und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Vaccines, Antibodies, Viral, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Washington Institute of Translational Health Science, National Institute of Allergy and Infectious Diseases, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) vaccination is recommended in pregnancy. Limited data exist regarding antibody (Ab) durability to inform revaccination timing. We conducted prospective cohort studies among pregnant and older adults after first RSV vaccination in 2023–2024. Longitudinal samples from 50 pregnant (36 vaccinated) and 16 vaccinated older adults were collected until 12–15 months after vaccination and tested for RSV binding and neutralizing Ab. Mean Ab levels 12–15 months after vaccination were similar between vaccinated maternal and older adult participants (P = .73), suggesting Ab durability up to 1 year after maternal RSV vaccination. RSV binding and neutralizing Ab titers were strongly correlated (R = .73).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus VaccinesAntibodies, ViralRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanHumansFemalePregnancyAntibodies, NeutralizingProspective StudiesPostpartum PeriodAdultAgedVaccinationLongitudinal Studies

Stichwörter der Autor:innen

RSV vaccine in pregnancyRespiratory syncytial virus (RSV)antibody durabilitymaternal immunization

Substanzen

Respiratory Syncytial Virus VaccinesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.
  • Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
  • Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • School of Medicine, University of Washington, Seattle, Washington, USA.
  • Department of Biostatistics, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Alisa Kachikis, Collrane Frivold, Mindy Pike, Jonathan C Reed, Jennifer E Stolarczuk, Kittredge McVey, Erica Clark, Marco Carone, Linda O Eckert, Alexander L Greninger, Janet A Englund, Helen Y Chu

Förderung

  • University of Washington Institute of Translational Health Science
  • National Institute of Allergy and Infectious Diseases
  • NIH
  • NCATS NIH HHS
  • NIAID NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Kachikis, A., Frivold, C., Pike, M., Reed, J. C., Stolarczuk, J. E., McVey, K., Clark, E., Mauer, C., McAteer, S., Saidac, I. M., Harteloo, A., Carone, M., Marshall, G., Eckert, L. O., Greninger, A. L., Englund, J. A., & Chu, H. Y. (2026). Comparison of Respiratory Syncytial Virus (RSV)–Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination. The Journal of Infectious Diseases, 234(1), e54-e59. https://doi.org/10.1093/infdis/jiag111

Vancouver

Kachikis A, Frivold C, Pike M, Reed JC, Stolarczuk JE, McVey K, et al. Comparison of Respiratory Syncytial Virus (RSV)–Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination. The Journal of Infectious Diseases. 2026;234(1):e54-e59. doi:10.1093/infdis/jiag111

BibTeX
@article{Kachikis2026,
  author = {Kachikis, Alisa and Frivold, Collrane and Pike, Mindy and Reed, Jonathan C and Stolarczuk, Jennifer E and McVey, Kittredge and Clark, Erica and Mauer, Clarice and McAteer, Sandra and Saidac, Ioana Maria and Harteloo, Alex and Carone, Marco and Marshall, Grace and Eckert, Linda O and Greninger, Alexander L and Englund, Janet A and Chu, Helen Y},
  title = {Comparison of Respiratory Syncytial Virus (RSV)–Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {234},
  number = {1},
  pages = {e54--e59},
  doi = {10.1093/infdis/jiag111}
}
Kostenlos starten →